CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
BACKGROUND: Obstructive sleep apnea is associated with an increased risk of cardiovascular events; whether treatment with continuous positive airway pressure (CPAP) prevents major cardiovascular events is uncertain.
METHODS: After a 1-week run-in period during which the participants used sham CPAP, we randomly assigned 2717 eligible adults between 45 and 75 years of age who had moderate-to-severe obstructive sleep apnea and coronary or cerebrovascular disease to receive CPAP treatment plus usual care (CPAP group) or usual care alone (usual-care group). The primary composite end point was death from cardiovascular causes, myocardial infarction, stroke, or hospitalization for unstable angina, heart failure, or transient ischemic attack. Secondary end points included other cardiovascular outcomes, health-related quality of life, snoring symptoms, daytime sleepiness, and mood.
RESULTS: Most of the participants were men who had moderate-to-severe obstructive sleep apnea and minimal sleepiness. In the CPAP group, the mean duration of adherence to CPAP therapy was 3.3 hours per night, and the mean apnea-hypopnea index (the number of apnea or hypopnea events per hour of recording) decreased from 29.0 events per hour at baseline to 3.7 events per hour during follow-up. After a mean follow-up of 3.7 years, a primary end-point event had occurred in 229 participants in the CPAP group (17.0%) and in 207 participants in the usual-care group (15.4%) (hazard ratio with CPAP, 1.10; 95% confidence interval, 0.91 to 1.32; P=0.34). No significant effect on any individual or other composite cardiovascular end point was observed. CPAP significantly reduced snoring and daytime sleepiness and improved health-related quality of life and mood.
CONCLUSIONS: Therapy with CPAP plus usual care, as compared with usual care alone, did not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease. (Funded by the National Health and Medical Research Council of Australia and others; SAVE ClinicalTrials.gov number, NCT00738179 ; Australian New Zealand Clinical Trials Registry number, ACTRN12608000409370 .).
Errataetall: |
CommentIn: N Engl J Med. 2016 Sep 8;375(10):994-6. - PMID 27571490 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:375 |
---|---|
Enthalten in: |
The New England journal of medicine - 375(2016), 10 vom: 08. Sept., Seite 919-31 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
McEvoy, R Doug [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 16.09.2016 Date Revised 10.04.2022 published: Print-Electronic ANZCTR: ACTRN12608000409370 ClinicalTrials.gov: NCT00738179 CommentIn: N Engl J Med. 2016 Sep 8;375(10):994-6. - PMID 27571490 Citation Status MEDLINE |
---|
doi: |
10.1056/NEJMoa1606599 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM26384398X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM26384398X | ||
003 | DE-627 | ||
005 | 20231224204801.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1056/NEJMoa1606599 |2 doi | |
028 | 5 | 2 | |a pubmed24n0879.xml |
035 | |a (DE-627)NLM26384398X | ||
035 | |a (NLM)27571048 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a McEvoy, R Doug |e verfasserin |4 aut | |
245 | 1 | 0 | |a CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.09.2016 | ||
500 | |a Date Revised 10.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a ANZCTR: ACTRN12608000409370 | ||
500 | |a ClinicalTrials.gov: NCT00738179 | ||
500 | |a CommentIn: N Engl J Med. 2016 Sep 8;375(10):994-6. - PMID 27571490 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Obstructive sleep apnea is associated with an increased risk of cardiovascular events; whether treatment with continuous positive airway pressure (CPAP) prevents major cardiovascular events is uncertain | ||
520 | |a METHODS: After a 1-week run-in period during which the participants used sham CPAP, we randomly assigned 2717 eligible adults between 45 and 75 years of age who had moderate-to-severe obstructive sleep apnea and coronary or cerebrovascular disease to receive CPAP treatment plus usual care (CPAP group) or usual care alone (usual-care group). The primary composite end point was death from cardiovascular causes, myocardial infarction, stroke, or hospitalization for unstable angina, heart failure, or transient ischemic attack. Secondary end points included other cardiovascular outcomes, health-related quality of life, snoring symptoms, daytime sleepiness, and mood | ||
520 | |a RESULTS: Most of the participants were men who had moderate-to-severe obstructive sleep apnea and minimal sleepiness. In the CPAP group, the mean duration of adherence to CPAP therapy was 3.3 hours per night, and the mean apnea-hypopnea index (the number of apnea or hypopnea events per hour of recording) decreased from 29.0 events per hour at baseline to 3.7 events per hour during follow-up. After a mean follow-up of 3.7 years, a primary end-point event had occurred in 229 participants in the CPAP group (17.0%) and in 207 participants in the usual-care group (15.4%) (hazard ratio with CPAP, 1.10; 95% confidence interval, 0.91 to 1.32; P=0.34). No significant effect on any individual or other composite cardiovascular end point was observed. CPAP significantly reduced snoring and daytime sleepiness and improved health-related quality of life and mood | ||
520 | |a CONCLUSIONS: Therapy with CPAP plus usual care, as compared with usual care alone, did not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease. (Funded by the National Health and Medical Research Council of Australia and others; SAVE ClinicalTrials.gov number, NCT00738179 ; Australian New Zealand Clinical Trials Registry number, ACTRN12608000409370 .) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Randomized Controlled Trial | |
700 | 1 | |a Antic, Nick A |e verfasserin |4 aut | |
700 | 1 | |a Heeley, Emma |e verfasserin |4 aut | |
700 | 1 | |a Luo, Yuanming |e verfasserin |4 aut | |
700 | 1 | |a Ou, Qiong |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xilong |e verfasserin |4 aut | |
700 | 1 | |a Mediano, Olga |e verfasserin |4 aut | |
700 | 1 | |a Chen, Rui |e verfasserin |4 aut | |
700 | 1 | |a Drager, Luciano F |e verfasserin |4 aut | |
700 | 1 | |a Liu, Zhihong |e verfasserin |4 aut | |
700 | 1 | |a Chen, Guofang |e verfasserin |4 aut | |
700 | 1 | |a Du, Baoliang |e verfasserin |4 aut | |
700 | 1 | |a McArdle, Nigel |e verfasserin |4 aut | |
700 | 1 | |a Mukherjee, Sutapa |e verfasserin |4 aut | |
700 | 1 | |a Tripathi, Manjari |e verfasserin |4 aut | |
700 | 1 | |a Billot, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Li, Qiang |e verfasserin |4 aut | |
700 | 1 | |a Lorenzi-Filho, Geraldo |e verfasserin |4 aut | |
700 | 1 | |a Barbe, Ferran |e verfasserin |4 aut | |
700 | 1 | |a Redline, Susan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jiguang |e verfasserin |4 aut | |
700 | 1 | |a Arima, Hisatomi |e verfasserin |4 aut | |
700 | 1 | |a Neal, Bruce |e verfasserin |4 aut | |
700 | 1 | |a White, David P |e verfasserin |4 aut | |
700 | 1 | |a Grunstein, Ron R |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Nanshan |e verfasserin |4 aut | |
700 | 1 | |a Anderson, Craig S |e verfasserin |4 aut | |
700 | 0 | |a SAVE Investigators and Coordinators |e verfasserin |4 aut | |
700 | 1 | |a Hedner, Jan |e investigator |4 oth | |
700 | 1 | |a Huang, Shaoguang |e investigator |4 oth | |
700 | 1 | |a Palmer, Lyle |e investigator |4 oth | |
700 | 1 | |a Freed, Ruth |e investigator |4 oth | |
700 | 1 | |a Cheung, Tina |e investigator |4 oth | |
700 | 1 | |a Espinosa, Natalie |e investigator |4 oth | |
700 | 1 | |a Leighton, Sarah |e investigator |4 oth | |
700 | 1 | |a Sassé, Tara |e investigator |4 oth | |
700 | 1 | |a Bailey, Kim |e investigator |4 oth | |
700 | 1 | |a Chintapatla, Swamy |e investigator |4 oth | |
700 | 1 | |a Freeman, Al |e investigator |4 oth | |
700 | 1 | |a Holder, Bryan |e investigator |4 oth | |
700 | 1 | |a Hosseini, Adele |e investigator |4 oth | |
700 | 1 | |a Leroux, Michelle |e investigator |4 oth | |
700 | 1 | |a Senior, Hugh |e investigator |4 oth | |
700 | 1 | |a Thomopoulos, Georgena |e investigator |4 oth | |
700 | 1 | |a Walsh, Robyn |e investigator |4 oth | |
700 | 1 | |a Wolfowicz, Zahara |e investigator |4 oth | |
700 | 1 | |a Jennings, Garry |e investigator |4 oth | |
700 | 1 | |a Marks, Guy |e investigator |4 oth | |
700 | 1 | |a Wong, K S Lawrence |e investigator |4 oth | |
700 | 1 | |a Mysore, Jayanthi |e investigator |4 oth | |
700 | 1 | |a Stepien, Sandrine |e investigator |4 oth | |
700 | 1 | |a Heritier, Stephane |e investigator |4 oth | |
700 | 1 | |a Guo, Xiheng |e investigator |4 oth | |
700 | 1 | |a Cao, Yongjun |e investigator |4 oth | |
700 | 1 | |a Campos, Carlos |e investigator |4 oth | |
700 | 1 | |a Delcourt, Candice |e investigator |4 oth | |
700 | 1 | |a Geovanini, Glaucylara |e investigator |4 oth | |
700 | 1 | |a Lau, Dennis |e investigator |4 oth | |
700 | 1 | |a Malavera, Alejandra |e investigator |4 oth | |
700 | 1 | |a Ooi, Eng Lee |e investigator |4 oth | |
700 | 1 | |a Santo, Karla |e investigator |4 oth | |
700 | 1 | |a Song, Lili |e investigator |4 oth | |
700 | 1 | |a Quan, Weiwei |e investigator |4 oth | |
700 | 1 | |a Wang, Min-Xia |e investigator |4 oth | |
700 | 1 | |a Wu, Guojun |e investigator |4 oth | |
700 | 1 | |a Yang, Jie |e investigator |4 oth | |
700 | 1 | |a Yap, Hooishan |e investigator |4 oth | |
700 | 1 | |a Zhang, Shihong |e investigator |4 oth | |
700 | 1 | |a Wolfowicz, Zahava |e investigator |4 oth | |
700 | 1 | |a Armenis, Manuela |e investigator |4 oth | |
700 | 1 | |a Byrne, Dominic |e investigator |4 oth | |
700 | 1 | |a Donnelly, Paul |e investigator |4 oth | |
700 | 1 | |a Baig, Mirza Ahmad |e investigator |4 oth | |
700 | 1 | |a Blacklock, Nick |e investigator |4 oth | |
700 | 1 | |a Monaghan, Helen |e investigator |4 oth | |
700 | 1 | |a Smith, Phillipa |e investigator |4 oth | |
700 | 1 | |a Glass, Parisa |e investigator |4 oth | |
700 | 1 | |a Malone, Magdalen |e investigator |4 oth | |
700 | 1 | |a Van Zyl, Marna |e investigator |4 oth | |
700 | 1 | |a Rodger, Carolyn |e investigator |4 oth | |
700 | 1 | |a Bandick, Laura |e investigator |4 oth | |
700 | 1 | |a O’Keefe, Michaela |e investigator |4 oth | |
700 | 1 | |a McKenna, Amanda |e investigator |4 oth | |
700 | 1 | |a Mercer, Jeremy |e investigator |4 oth | |
700 | 1 | |a Jurisevic, Mark |e investigator |4 oth | |
700 | 1 | |a Mead, Samantha |e investigator |4 oth | |
700 | 1 | |a Klauber, Adrian |e investigator |4 oth | |
700 | 1 | |a Cox, Leanne |e investigator |4 oth | |
700 | 1 | |a Paul, Denzil |e investigator |4 oth | |
700 | 1 | |a Tutya, Sergio |e investigator |4 oth | |
700 | 1 | |a Betito, Alessandro |e investigator |4 oth | |
700 | 1 | |a Moia, Diogo |e investigator |4 oth | |
700 | 1 | |a Marinho, Joyce |e investigator |4 oth | |
700 | 1 | |a Cavalcante, Lara |e investigator |4 oth | |
700 | 1 | |a Ying, Shu |e investigator |4 oth | |
700 | 1 | |a Zheng, Yuehan |e investigator |4 oth | |
700 | 1 | |a Wei, Wei |e investigator |4 oth | |
700 | 1 | |a Zhang, Hongyu |e investigator |4 oth | |
700 | 1 | |a Zhou, Jing |e investigator |4 oth | |
700 | 1 | |a Jia, Haijing |e investigator |4 oth | |
700 | 1 | |a Zhaung, Meng |e investigator |4 oth | |
700 | 1 | |a Chen, Xiaoying |e investigator |4 oth | |
700 | 1 | |a Cui, Buliang |e investigator |4 oth | |
700 | 1 | |a Deng, Hua |e investigator |4 oth | |
700 | 1 | |a Ding, Xiaofen |e investigator |4 oth | |
700 | 1 | |a Li, Nan |e investigator |4 oth | |
700 | 1 | |a Lin, Hui |e investigator |4 oth | |
700 | 1 | |a Liu, Bochen |e investigator |4 oth | |
700 | 1 | |a Song, Aiwu |e investigator |4 oth | |
700 | 1 | |a Sun, Jian |e investigator |4 oth | |
700 | 1 | |a Wang, Sai Nan |e investigator |4 oth | |
700 | 1 | |a Zhao, Feifei |e investigator |4 oth | |
700 | 1 | |a Zhuang, Ying |e investigator |4 oth | |
700 | 1 | |a Boyini, Hemalata |e investigator |4 oth | |
700 | 1 | |a Kunigari, Mallikarjuna |e investigator |4 oth | |
700 | 1 | |a Viejo, Esther |e investigator |4 oth | |
700 | 1 | |a Mayoral, Nieves |e investigator |4 oth | |
700 | 1 | |a Rubio, Javier |e investigator |4 oth | |
700 | 1 | |a Boeing, B M |e investigator |4 oth | |
700 | 1 | |a Hillman, D |e investigator |4 oth | |
700 | 1 | |a Rea, S C |e investigator |4 oth | |
700 | 1 | |a Anderson, C A |e investigator |4 oth | |
700 | 1 | |a Carcel, C |e investigator |4 oth | |
700 | 1 | |a Ray, E |e investigator |4 oth | |
700 | 1 | |a Paraskevaidis, T |e investigator |4 oth | |
700 | 1 | |a Small, S |e investigator |4 oth | |
700 | 1 | |a Levitt, J |e investigator |4 oth | |
700 | 1 | |a Douglas, J |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 375(2016), 10 vom: 08. Sept., Seite 919-31 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
773 | 1 | 8 | |g volume:375 |g year:2016 |g number:10 |g day:08 |g month:09 |g pages:919-31 |
856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMoa1606599 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 375 |j 2016 |e 10 |b 08 |c 09 |h 919-31 |